Quick Takeaways
- Luke Evnin has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,166,324.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Luke Evnin
- Location
- Boston, MA
- Summary
- The estimated net worth of Luke Evnin is at least $1,166,324 dollars as of 20 Jan 2026. Luke Evnin is the Director of Werewolf Therapeutics, Inc. and owns shares of Werewolf Therapeutics, Inc. (HOWL) stock worth about $1.17M.
- Signature
- /s/ Luke Evnin
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Luke Evnin and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Werewolf Therapeutics, Inc. ($1,166,324).
- Past-year value change for that position: -$2,078,052.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Luke Evnin
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | Director | $1,166,324 | -$2,078,052 | -64% | 16 Jan 2026 |
| ONCR | Oncorus, Inc. | Director | 23 Jun 2022 |
Insider Transactions Reported by Luke Evnin:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.